相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preclinical Development of CD38-Targeted [89Zr] Zr-DFO-Daratumumab for Imaging Multiple Myeloma
Anchal Ghai et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Copper 64-labeled daratumumab as a PET/CT imaging tracer for multiple myeloma
Enrico Caserta et al.
BLOOD (2018)
Comparison of Immuno-PET of CD138 and PET imaging with 64CuCl2 and 18F-FDG in a preclinical syngeneic model of multiple myeloma
Clément Bailly et al.
Oncotarget (2018)
Copper radiopharmaceuticals for theranostic applications
Anife Ahmedova et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Syndecan-1 promotes Wnt/β-catenin signaling in multiple myeloma by presenting Wnts and R-spondins
Zemin Ren et al.
BLOOD (2018)
Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings
Giulia Anna Follacchio et al.
CURRENT RADIOPHARMACEUTICALS (2018)
Molecular Drug Imaging: 89Zr-Bevacizumab PET in Children with Diffuse Intrinsic Pontine Glioma
Marc H. Jansen et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab
Christopher G. England et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients
Clement Bailly et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
ImmunoPET imaging of tissue factor expression in pancreatic cancer with 89Zr-Df-ALT-836
Reinier Hernandez et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
Michele Cavo et al.
LANCET ONCOLOGY (2017)
Development of Novel ImmunoPET Tracers to Image Human PD-1 Checkpoint Expression on Tumor-Infiltrating Lymphocytes in a Humanized Mouse Model
Arutselvan Natarajan et al.
MOLECULAR IMAGING AND BIOLOGY (2017)
PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer
Judith van Loon et al.
RADIOTHERAPY AND ONCOLOGY (2017)
89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer
Gary A. Ulaner et al.
CLINICAL NUCLEAR MEDICINE (2017)
89Zr-Immuno-Positron Emission Tomography in Oncology: State-of the-Art 89Zr Radiochemistry
Sandra Heskamp et al.
BIOCONJUGATE CHEMISTRY (2017)
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. Moreau et al.
ANNALS OF ONCOLOGY (2017)
Immuno-PET for Clinical Theranostic Approaches
Clement Bailly et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives
S. Lonial et al.
LEUKEMIA (2016)
Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT
Gary A. Ulaner et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody
Reinier Hernandez et al.
THERANOSTICS (2016)
Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?
Yvonne W. S. Jauw et al.
FRONTIERS IN PHARMACOLOGY (2016)
In Vivo Integrity and Biological Fate of Chelator-Free Zirconium-89-Labeled Mesoporous Silica Nanoparticles
Feng Chen et al.
ACS NANO (2015)
Single-dose anti-cd138 radioimmunotherapy: bismuth-213 is more efficient than lutetium-177 for treatment of multiple myeloma in a preclinical model
Nolwenn Fichou et al.
FRONTIERS IN MEDICINE (2015)
The impact of intra-clonal heterogeneity on the treatment of multiple myeloma
Annamaria Brioli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Comparative analysis of multiple myeloma treatment by CD138 antigen targeting with bismuth-213 and Melphalan chemotherapy
S. Gouard et al.
NUCLEAR MEDICINE AND BIOLOGY (2014)
Pilot study of 89Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancer
Idris Bahce et al.
EJNMMI RESEARCH (2014)
213Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma
Michel Cherel et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Tissue Distribution Studies of Protein Therapeutics Using Molecular Probes: Molecular Imaging
Simon-Peter Williams
AAPS JOURNAL (2012)
Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients
Caroline Rousseau et al.
TUMOR BIOLOGY (2012)
In vivo biodistribution and accumulation of 89Zr in mice
Diane S. Abou et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
Jason P. Holland et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Disparity Between In Vivo EGFR Expression and 89Zr-Labeled Cetuximab Uptake Assessed with PET
Hugo J. W. L. Aerts et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Syndecan-1: a dynamic regulator of the myeloma microenvironment
Ralph D. Sanderson et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Preparation and evaluation of 89Zr-Zevalin for monitoring of 90Y-Zevalin biodistribution with positron emission tomography
Lars R. Perk et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
分享论文
